Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia
NCT ID: NCT05327985
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
21 participants
OBSERVATIONAL
2024-09-10
2025-07-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presenting with a diagnosed focal CD with predominantly rotational by a neurologist specialized in abnormal movements
* Receiving botulinum toxin injection at OIC level as part of his treatment
* Express consent to participate in the study
* Member of or beneficiary of a social security scheme
Exclusion Criteria
* Having already benefited from an injection of BoNT as part of their DC in the last three months
* Inability to sit still
* Neurological condition other than DC (parkinsonian syndrome typical or atypical, others.)
* Severe neck pain
* Known or suspected trauma or pathology of the cervical spine, other than DC, having required treatment in the last 6 month
* Same old surgery of the cervical spine
* Patient benefiting from a legal protection measure
* Pregnant or breastfeeding women (a urine pregnancy test will be carried out in women under 50)
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Pierre Bleton
Role: PRINCIPAL_INVESTIGATOR
Hopital Fondation Adolphe de Rothschild
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Fondation Adolphe de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JBN_2022_1
Identifier Type: -
Identifier Source: org_study_id